More than 30 high-level experts from the worlds of policy and research in Europe and Japan convened in Tokyo to discuss issues such as funding, training, and mobility opportunities for young researchers.
EMBO invited its 1800 Members and 150 Young Investigators to report on any efforts they or their institutions are making to help fight the ongoing COVID-19 pandemic.
The spread of the novel coronavirus (SARS-CoV-2) is continuing to quickly evolve in many countries. EMBO is continuing to monitor the situation closely to help prevent potential health and financial impact from the outbreak on EMBO Fellows, organizers of EMBO-funded events and the participants, and EMBO staff.
Travel information and advice regarding coronavirus
On 7-11 December 2019, the annual ASCB|EMBO Meeting took place in Washington DC, USA. The meeting brings together life scientists from around the world.
EMBO has removed the 40-year age limit from the eligibility criteria for the Young Investigator Programme.
Although the United Kingdom is leaving the European Union today, scientists based in the UK will continue to have access to all EMBO Programmes and activities.
EMBO Molecular Medicine (EMM), one of five journals published by EMBO Press, was established in 2009 for the purpose of publishing the best work at the interface between clinical research and molecular cell biology. In its tenth anniversary year, we highlight ten characteristics that have helped to establish EMM in the world of scientific publishing.
EMBO and EMBO Press are making their journals’ finances public to provide transparency and clarity about what it costs to publish articles in high quality, selective journals.
Peer Review Week, a series of events to highlight the essential role of peer review in scientific publishing, takes place for the fifth time this year. This year’s focus on quality in peer review offers an opportunity for EMBO Press to celebrate a decade of transparent peer review.
